Guideline adherence in the management of aromatase inhibitor-induced bone loss in women with breast cancer
{{output}}
Purpose: Osteoporosis (OP) and aromatase inhibitor (AI)-induced bone loss are major concerns among postmenopausal women with breast cancer. This study aimed to comparatively evaluate guideline-concordant bone health management fo... ...
